Key facts
- It has raised $3.4M; the latest was Seed Round ($2.7M) in Aug 2025.
- Notable investors include Shilling (Portugal), Exceptional Ventures, ScaleUps Ventures, Abac Nest Ventures, Deuce Capital — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Punto Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Punto Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Punto Health
Developer of a personalized artificial intelligence assistant platform designed for cognitive care. The company's platform connects patients, families, and providers with continuous support through a trusted companion from early detection of mild cognitive impairment to advanced dementia stages, enabling people to plan, set reminders, communicate, and take tests from home.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2023
- Employees
- 8
- Website
- puntohealth.com/
- Ownership
- Privately Held (backing)
Punto Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Punto Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Punto Health in its N-PORT filings yet. We sweep new filings monthly.